Chimeric Fibril-Reactive Monoclonal Anti-body 11-1F4 ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
28	Systemic amyloidosis	1

28. Systemic amyloidosis

Clinical trials : 267 / Drugs : 241 - (DrugBank : 77) / Drug target genes : 68 - Drug target pathways : 180

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02245867 (ClinicalTrials.gov)	December 2, 2014	15/9/2014	Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis	Phase Ia/Ib Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloid ...	Amyloidosis	Drug: Chimeric Fibril-Reactive Monoclonal Anti-body 11-1F4	Andrew Eisenberger	NULL	Completed	21 Years	N/A	All	31	Phase 1	United States

First Previous1Next Last